Early detection of MS treatment complication may improve survival

(American Academy of Neurology) The drug natalizumab is effective for treating multiple sclerosis, but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML). A study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, Mar. 16 to 23, 2013, suggests that early detection of PML may help improve survival and disability levels.
Source: EurekAlert! - Social and Behavioral Science - Category: Global & Universal Source Type: news